


| Molecular Weight | 1179.4 g/mol |
|---|---|
| Molecular Formula | C68H74N8O11 |
| XLogP3 | 5.2 |
| Hydrogen Bond Donor Count | 10 |
| Hydrogen Bond Acceptor Count | 15 |
| Rotatable Bond Count | 18 |
| Exact Mass | 1178.54770521 g/mol |
| Monoisotopic Mass | 1178.54770521 g/mol |
| Topological Polar Surface Area | 314 Ų |
| Heavy Atom Count | 87 |
| Formal Charge | 0 |
| Complexity | 2360 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 4 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 2 | |
|---|---|
| Drug Name | Photofrin |
| PubMed Health | Porfimer (Injection) |
| Drug Classes | Antineoplastic Agent |
| Drug Label | PHOTOFRIN (porfimer sodium) for Injection is a photosensitizing agent used in the photodynamic therapy (PDT) of tumors and of high-grade dysplasia (HGD) in Barretts esophagus (BE). Following reconstitution of the freeze-dried product with 5% Dex... |
| Active Ingredient | Porfimer sodium |
| Dosage Form | Injectable |
| Route | injection; Injection |
| Strength | 75mg/vial |
| Market Status | Prescription |
| Company | Axcan Scandipharm; Pinnacle Biolgs |
| 2 of 2 | |
|---|---|
| Drug Name | Photofrin |
| PubMed Health | Porfimer (Injection) |
| Drug Classes | Antineoplastic Agent |
| Drug Label | PHOTOFRIN (porfimer sodium) for Injection is a photosensitizing agent used in the photodynamic therapy (PDT) of tumors and of high-grade dysplasia (HGD) in Barretts esophagus (BE). Following reconstitution of the freeze-dried product with 5% Dex... |
| Active Ingredient | Porfimer sodium |
| Dosage Form | Injectable |
| Route | injection; Injection |
| Strength | 75mg/vial |
| Market Status | Prescription |
| Company | Axcan Scandipharm; Pinnacle Biolgs |